Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patients

Cytokine

Volumn 60, Issue 1, 2012, Pages 249-256

  Watanabe, Eizo ^a,b   Zehnbauer, Barbara A ^a,c   Oda, Shigeto ^b   Sato, Yasunori ^b   Hirasawa, Hiroyuki ^b   Buchman, Timothy G ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Genetic predisposition to Disease; Genetic testing; Sepsis; Ventilators, mechanical

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CAUCASIAN; CD14 GENE; CRITICALLY ILL PATIENT; FEMALE; GENE; GENETIC PREDISPOSITION; GENOTYPE; HEALTH CARE UTILIZATION; HOMOZYGOTE; HUMAN; INNATE IMMUNITY; INTENSIVE CARE; INTERLEUKIN 1BETA GENE; KAPLAN MEIER METHOD; LYMPHOTOXIN ALPHA GENE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR GENE; UNITED STATES; VENTILATED PATIENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SEPSIS; SURVIVAL RATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTILATORS, MECHANICAL; YOUNG ADULT;

EID: 84865418513     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.016     Document Type: Article

References (38)

1. Faist E., Baue A.E., Dittmer H., Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983, 23:775-787.
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
3. Teuffel O., Ethier M.C., Beyene J., Sung L. Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 2010, 38:276-282.
4. Lin M.T., Albertson T.E. Genomic polymorphisms in sepsis. Crit Care Med 2004, 32:569-579.
5. Freeman B.D., Kennedy C.R., Frankel H.L., Clarridge B., Bolcic-Jankovic D., Iverson E., et al. Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?. Pharmacogenomics J 2010, 10:77-85.
6. Arcaroli J., Fessler M.B., Abraham E. Genetic polymorphisms and sepsis. Shock 2005, 24:300-312.
7. Terwilliger J.D., Haghighi F., Hiekkalinna T.S., Goring H.H. A bias-ed assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev 2002, 12:726-734.
8. Clark M.F., Baudouin S.V. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 2006, 32:1706-1712.
9. Watanabe E., Zehnbauer B., Deutschman C.S. Genetic variability and outcome in the critically ill: avoiding SNP judgments. Crit Care Med 2009, 37:357-360.
10. Watanabe E., Buchman T.G., Hirasawa H., Zehnbauer B.A. Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med 2010, 38:181-193.
11. Kilgannon J.H., Jones A.E., Shapiro N.I., Angelos M.G., Milcarek B., Hunter K., et al. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 2010, 303:2165-2171.
12. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101:1644-1655.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-74.
14. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
15. Schoenfeld D.A., Bernard G.R. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002, 30:1772-1777.
16. Weycker D., Akhras K.S., Edelsberg J., Angus D.C., Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003, 31:2316-2323.
17. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992, 48:361-372.
18. McGuire W., Hill A.V., Allsopp C.E., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508-510.
19. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
20. Heininger A., Haeberle H., Fischer I., Beck R., Riessen R., Rohde F., et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011, 15:R77.
21. Shimada T., Oda S., Sadahiro T., Nakamura M., Hirayama Y., Watanabe E., et al. Outcome prediction in sepsis combined use of genetic polymorphisms - a study in Japanese population. Cytokine 2010, 54:79-84.
22. Zehnbauer B. Population genetics in critical illness. Crit Care Med 2005, 33:242-243.
23. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91.
24. Watanabe E., Hirasawa H., Oda S., Shiga H., Matsuda K., Nakamura M., et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005, 59:1181-1189. [Discussion 1189-1190].
25. Winning J., Claus R.A., Huse K., Bauer M. Molecular biology on the ICU. From understanding to treating sepsis. Minerva Anestesiol 2006, 72:255-267.
26. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
27. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
28. Oda S., Hirasawa H., Shiga H., Nakanishi K., Matsuda K., Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29:169-175.
29. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
30. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487.
31. Watanabe E., Hirasawa H., Oda S., Matsuda K., Hatano M., Tokuhisa T. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005, 33:89-97. [Discussion 242-243].
32. Russell J.A. Management of sepsis. N Engl J Med 2006, 355:1699-1713.
33. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E. Cell death. N Engl J Med 2009, 361:1570-1583.
34. Waterer G.W., Quasney M.W., Cantor R.M., Wunderink R.G. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001, 163:1599-1604.
35. Shalhub S., Junker C.E., Imahara S.D., Mindrinos M.N., Dissanaike S., O'Keefe G.E. Variation in the TLR4 gene influences the risk of organ failure and shock post trauma: a cohort study. J Trauma 2009, 66:115-122. [Discussion 122-113].
36. Otani S., Oda S., Sadahiro T., Nakamura M., Watanabe E., Nakada T.A., et al. Clinical application of cytokine-related gene polymorphism analysis using a newly developed DNA chip in critically ill patients. Clin Biochem 2009, 42:1387-1393.
37. Cobb J.P., Brownstein B.H., Watson M.A., Shannon W.D., Laramie J.M., Qiu Y., et al. Injury in the era of genomics. Shock 2001, 15:165-170.
38. Ashley E.A., Butte A.J., Wheeler M.T., Chen R., Klein T.E., Dewey F.E., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.